Conference-abstractEur Rev Med Pharmacol Sci2020
MiR-4282 contributes to inhibit pancreatic cancer metastasis by negatively interacting with ABCB5.
- Journal
- Eur Rev Med Pharmacol Sci
- Published
- 1 October 2020
- Citations
- 6
- Type
- Conference-abstract
These are the paper’s bibliographic details. A summary of its population, design, endpoints and findings, each tied to a quote, has not been written for this paper yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
abstract license unknown
Objective To explore the regulatory mechanism of microRNA-4282 (miR-4282) on influencing pancreatic cancer progression by targeting ABCB5. Patients and methods MiR-4282 and ABCB5 levels in 58 cases of pancreatic cancer and paracancerous tissues were detected by quantitative Real Time-Polymerase Chain Reaction (qRT-PCR). … Excerpt only: this text is the publisher’s. Read it in full at the source.